The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Merck Sharp & Dohme BV,EU/1/06/337/1-13

Main Information

Active SubstancesMumps virus live attenuated jeryl lynn strain
Rubella virus (wistar ra 27/3 strain) live attenuated
Measles virus live attenuated derived from the edmonston b strain
Dosage FormPowder and solvent for suspension for injection
Licence HolderMerck Sharp & Dohme BV,
Licence NumberEU/1/06/337/1-13

Group Information

ATC CodeJ07BD Measles vaccines
J07BD52 measles, combinations with mumps and rubella, live attenuated


License statusAuthorised
Licence Issued05/05/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back